Teva Pharmaceutical Industries Ltd 

TEVA:NYSE

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
38.22 0.04   0.10%3.15%2,265,5673.0M

Market data is delayed by at least 20 minutes.
Market is closed. As of 03:59 PM ET 8/30/2013
 
 
 

Latest News Headlines for Teva Pharmaceutical Industries Ltd

Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL(R)) in Patients with Major Depression Associated with Bipolar I Disorder
1 days 6 hours 10 minutes ago - BusinessWire via Dow Jones News
JERUSALEM--(BUSINESS WIRE)--August 30, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced top-line results of its final Phase III clinical study for armodafinil (NUVIGIL(R) ) as adjunct therapy in adults with major depression associated with bipolar I disorder. The study reached statistical significance in several important secondary endpoints, such as responder rate and remission. However, it did not reach its primary endpoint --to determine whether armodafinil treatment (150mg per day) is more effective than placebo as adjunct therapy to mood stabilizers and/or atypical antipsychotics.
View more recent headlines
 
 
 
Company Background
Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. Teva's active pharmaceutical ingredient (API) business provides vertical integration to Teva's own pharmaceutical production. The Company's global operations are conducted from North and Latin America to Europe and Asia. Teva operates a number of subsidiaries in such countries as Canada, Croatia, the Czech Republic, France, Germany, Hungary, Ireland, Israel, Japan, Poland, the Russian Federation, Spain, the Netherlands, the United Kingdom and the United States.

Bid/Size
-- / --
Ask/Size
-- / --
Price Open
38.37
Previous Close
38.18
Day High
38.44
Day Low
38.18
52wk High/Date
42.83 / 12/10/2012
52wk Low/Date
36.63 / 12/31/2012
% off 52wk High
-10.76%
% off 52wk Low
4.34%
Beta (5 Yr)
0.4
Market Capitalization
32.5B
Shares Outstanding
851.0M
Volatility Avg
16.89
EPS(TTM)
0.48
P/E Ratio
79.4
Dividend Announcement
8/1/2013
Dividend Yield
3.15%
Ex-Date
8/16/2013
Date of Record
8/20/2013
Payable
0.3219 - QRTR
Payable Date
9/3/2013
Last Trade as of 8/30/2013 4:07 PM ET
 
 
 

TEVA Teva Pharmaceutical Industries Ltd vs. Peers

Peers 
TEVA
Teva Pharmaceutical Industries Ltd
2.36%
Momenta Pharmaceuticals, Inc.
19.51%
TEVA
Teva Pharmaceutical Industries Ltd
3.15%
Momenta Pharmaceuticals, Inc.
--
TEVA
Teva Pharmaceutical Industries Ltd
0.10%
Momenta Pharmaceuticals, Inc.
-1.61%
Compare these stocks